{"title":"对于心血管事件高风险的2型糖尿病患者,与安慰剂相比,口服西马鲁肽是否能降低主要不良心血管事件的风险,它是否安全?]","authors":"Alexandre Mutchmore , Mathieu Labossière , Michel Cauchon , Marc-Émile Plourde , Luc Lanthier","doi":"10.1016/j.revmed.2025.05.010","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":54458,"journal":{"name":"Revue De Medecine Interne","volume":"46 7","pages":"Pages 436-437"},"PeriodicalIF":0.9000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chez les personnes avec diabète de type 2 à risque cardiovasculaire élevé, est-ce que le sémaglutide oral est efficace et sécuritaire pour diminuer les évènements cardiovasculaires majeurs comparativement au placébo ?\",\"authors\":\"Alexandre Mutchmore , Mathieu Labossière , Michel Cauchon , Marc-Émile Plourde , Luc Lanthier\",\"doi\":\"10.1016/j.revmed.2025.05.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":54458,\"journal\":{\"name\":\"Revue De Medecine Interne\",\"volume\":\"46 7\",\"pages\":\"Pages 436-437\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2025-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue De Medecine Interne\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0248866325006216\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue De Medecine Interne","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0248866325006216","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Chez les personnes avec diabète de type 2 à risque cardiovasculaire élevé, est-ce que le sémaglutide oral est efficace et sécuritaire pour diminuer les évènements cardiovasculaires majeurs comparativement au placébo ?
期刊介绍:
Official journal of the SNFMI, La revue de medecine interne is indexed in the most prestigious databases. It is the most efficient French language journal available for internal medicine specialists who want to expand their knowledge and skills beyond their own discipline. It is also the main French language international medium for French research works. The journal publishes each month editorials, original articles, review articles, short communications, etc. These articles address the fundamental and innumerable facets of internal medicine, spanning all medical specialties. Manuscripts may be submitted in French or in English.
La revue de medecine interne also includes additional issues publishing the proceedings of the two annual French meetings of internal medicine (June and December), as well as thematic issues.